Open AccessCombined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance
Author(s) -
Fleur V.Y. Tjong,
Tom F. Brouwer,
Lonneke Smeding,
Kirsten M. Kooiman,
Joris R. de Groot,
David Ligon,
Rick Sanghera,
Martin J. Schalij,
Arthur A.M. Wilde,
Reinoud E. Knops
Publication year - 2016
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euv457
Subject(s) - medicine , cardiology , programmer , intracardiac injection , implantable cardioverter defibrillator , defibrillation , cardioversion , atrial fibrillation , programming language , computer science
The subcutaneous implantable cardioverter-defibrillator (S-ICD) and leadless pacemaker (LP) are evolving technologies that do not require intracardiac leads. However, interactions between these two devices are unexplored. We investigated the feasibility, safety, and performance of combined LP and S-ICD therapy, considering (i) simultaneous device-programmer communication, (ii) S-ICD rhythm discrimination during LP communication and pacing, and (iii) post-shock LP performance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom